Showing results (591-600 of 989) with videos related to
Sort By:
Pageof 99
Breast Cancer Research : BCR|March 24, 2017
Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic functionMuge Sarper, Michael D Allen, Jenny Gomm, et al.Clinical Colorectal Cancer|January 7, 2011
Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinomaAllyson J Ocean, Blase Polite, Paul Christos, et al.Endoscopy|August 4, 2007
Hydrogen peroxide-related colitis (previously known as "pseudolipomatosis"): a series of cases occurring in an epidemic patternG Cammarota, P Cesaro, A Cazzato, et al.NPJ Breast Cancer|February 9, 2022
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancerJoseph A Sparano, Anne O'Neill, Noah Graham, et al.Medical Oncology (Northwood, London, England)|November 20, 1998
Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferonR K Alpaugh, M von Mehren, I Palazzo, et al.Cancer Treatment Reviews|April 24, 2012
Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumorsJohn M Kirkwood, Ahmad Tarhini, Joseph A Sparano, et al.Blood|May 26, 2005
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010Lawrence D Kaplan, Jeannette Y Lee, Richard F Ambinder, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1997
Urinary estrogen metabolites and breast cancer: a case-control studyG C Kabat, C J Chang, J A Sparano, et al.Cancer|August 10, 2022
Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancerRima Patel, Malin Hovstadius, Melanie W Kier, et al.JCO Global Oncology|November 14, 2024
Health-Related Quality of Life and Financial Burden in Ethiopian Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional StudyFisihatsion Tadesse, Francesco Sparano, Amha Gebremedhin, et al.Pageof 99